Meu SciELO
Serviços Personalizados
Journal
Artigo
Indicadores
Citado por SciELO
Acessos
Links relacionados
Citado por Google
Similares em SciELO
Similares em Google
Compartilhar
Revista Española de Enfermedades Digestivas
versão impressa ISSN 1130-0108
Resumo
FORTEA ORMAECHEA, José Ignacio et al. Long-term remission with rituximab in a patient with severe hepatitis C virus-induced mixed cryoglubulinemia. Rev. esp. enferm. dig. [online]. 2013, vol.105, n.8, pp.490-493. ISSN 1130-0108. https://dx.doi.org/10.4321/S1130-01082013000800009.
Mixed cryoglobulinemia (MC) is a small-vessel systemic vasculitis characterized by the presence of cryoglobulins, immunoglobulin complexes that precipitate at low temperatures (< 37 oC) inducing the inflammatory process. The most frequent etiology is hepatitis C infection (HCV) (1). Rituximab (RTX), an anti-CD20 monoclonal antibody, has recently emerged as the treatment of choice for severe MC (2). We present a case of severe hepatitis C virus-induced MC that was controlled and maintained in remission with RTX for 26 months, a remarkable prolonged period of time.
Palavras-chave : Cryoglobulinemia; Rituximab; Hepatitis C infection.